Double or triple down: how AFT Pharmaceuticals plans to win in China

Double or triple down: how AFT Pharmaceuticals plans to win in China
(Image: Getty)
Rebecca Stevenson
AFT Pharmaceuticals says it has increased manufacturing capacity and brought in market experts as it prepares to launch its antibacterial cream in China. The New Zealand Exchange-listed (NZX) firm reported its results for the 12 months to March 31 on May 23. Its international and Asian sales rose 70%, accounting for 20% of revenue. Operating revenue for AFT’s Asian business grew 57% to $10.7 million from $6.8m, while operating profit rose to $2.5m from $900,000.It said growth was driven through the hospital channel, wi...

More Markets

NZ shares fall on economic fears
Markets Market close

NZ shares fall on economic fears

The S&P/NZX 50 index dropped 96.21 points, or 0.8%, to 11,671.19.

Carbon auction gets zero bids
Markets

Carbon auction gets zero bids

There was no interest in the 4 million units on offer.

$2.2m spent, no takeover for Rakon
Markets

$2.2m spent, no takeover for Rakon

Chip-maker fumbled the bag, research analyst says.

Fletcher's Fiji sale snares $20m
Markets

Fletcher's Fiji sale snares $20m

Fletcher has been urged to divest non-core businesses to shore up its finances.